Dena R Howard
6PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 26, 2022
Obinutuzumab as consolidation after chemo-immunotherapy: Results of the UK National Cancer Research Institute phase II/III GALACTIC trial.Talha Munir, Jake Emmerson, Anna Hockaday
|May 24, 2021
COSMIC, chemotherapy plus ofatumumab at standard or mega-dose in chronic lymphocytic leukaemia, a phase II randomised study.David Allsup, Dena Howard, Jake Emmerson
|Jan 09, 2021
A platform trial in practice: adding a new experimental research arm to the ongoing confirmatory FLAIR trial in chronic lymphocytic leukaemia.Dena R Howard, Anna Hockaday, Julia M Brown
|Aug 23, 2019
Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials.Tomasz K Wojdacz, Harindra E Amarasinghe, Latha Kadalayil
|Mar 25, 2017
Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL.D R Howard, T Munir, L McParland
|Dec 30, 2016
Eradication of minimal residual disease improves overall and progression-free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: a phase II trial assessing alemtuzumab consolidation.Abraham M Varghese, Dena R Howard, Christopher Pocock
Pageof 1
Frequent Collaborators
2 joint publications
David Allsup
2 joint publications
Peter Hillmen
1 joint publications
A C Rawstron
1 joint publications
Talha Munir
1 joint publications
Latha Kadalayil
1 joint publications
Pauline Robbe
1 joint publications
Andrew J Steele
1 joint publications
Anna Schuh
1 joint publications
Matthew J J Rose-Zerilli
1 joint publications
Jonathan C Strefford
